Tumors were classified into four categories based on mutation burden: high NUSAP+ Glioma score with high TMB, high NUSAP+ Glioma score with low TMB, low NUSAP+ Glioma score with high TMB, and low NUSAP+ Glioma score with low TMB. This evidence concerns the gene NUSAP1 and glioma.